CORONAVIRUS

Pfizer asks US officials to OK promising COVID-19 pill

Nov 16, 2021, 1:01 PM
Pfizer Inc. signage is seen on July 22, 2020, in New York City. (Photo by Jeenah Moon/Getty Images)...
Pfizer Inc. signage is seen on July 22, 2020, in New York City. (Photo by Jeenah Moon/Getty Images)
(Photo by Jeenah Moon/Getty Images)

WASHINGTON (AP) — Pfizer said Tuesday it is asking U.S. regulators to authorize its experimental pill for COVID-19, setting the stage for a likely launch of the promising therapy in the coming weeks.

The company’s filing comes as new infections are rising once again, driven mainly by hot spots in states where colder weather is driving more Americans indoors.

It is one of a handful of pills that have recently been shown to significantly cut hospitalizations and deaths among people infected with COVID-19. If authorized by the Food and Drug Administration it could be a major step toward managing the pandemic and returning to normal, offering an easy, effective way for patients people to treat themselves at home.

“We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients, and we look forward to working with the U.S. FDA on its review of our application,” said Albert Bourla, Pfizer’s CEO, in a statement.

All FDA authorized treatments against COVID-19 require an IV or injection given by a health professional at a hospital or clinic.

FDA regulators will scrutinize company data on the safety and effectiveness of the drug, which will be sold as Paxlovid, before making a decision.

The FDA is holding a public meeting later this month where outside experts will scrutinize a competing drug from Merck, before voting on whether to recommend approval. The FDA isn’t required to convene such meetings and it’s not yet known whether Pfizer’s drug will undergo a similar public review.

Some experts predict various COVID-19 therapies eventually will be prescribed in combination to better protect against the worst effects of the virus.

Several smaller drugmakers are also expected to seek authorization for their own antiviral pills in coming months.

Pfizer reported earlier this month that its pill cut hospitalizations and deaths by 89% among high-risk adults who had early symptoms of COVID-19. The company studied its pill in people who were unvaccinated and faced the worst risks from the virus due to age or health problems, such as obesity. If authorized, the FDA will have to weigh making the pill available for vaccinated people dealing with breakthrough infections.

For best results, patients need to start taking the pills within three days of symptoms, underscoring the need for speedy testing and diagnosis. That could be a challenge if another COVID-19 surge leads to testing delays and shortages seen last winter.

Pfizer’s drug is part of a decades-old family of antiviral drugs known as protease inhibitors, which revolutionized the treatment of HIV and hepatitis C. The drugs block a key enzyme which viruses need to multiply in the human body. That’s different than the Merck pill, which causes tiny mutations in the coronavirus until the point that it can’t reproduce itself.

On Tuesday, Pfizer signed a deal a with U.N.-backed group to allow generic drugmakers to produce low-cost versions of the drug for use in 95 countries, a move that could make the treatment available in more than half of the world’s population.

The U.S. has approved one other antiviral drug for COVID-19, remdesivir, and authorized three antibody therapies that help the immune system fight the virus. But they usually have to be given via time-consuming infusions at hospitals or clinics, and limited supplies were strained by the last surge of the delta variant.

___

Follow Matthew Perrone on Twitter: @AP_FDAwriter

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

KSL 5 TV Live

Top Stories

Coronavirus

FILE PHOTO (Photo by Jacob King - WPA Pool/Getty Images)...
MIKE STOBBE, AP Medical Writer

Moderna COVID-19 shots now an option for older kids in US

There is now a second COVID-19 option for kids ages 6 to 17 in the U.S.
4 days ago
Pfizer says it's COVID-19 vaccine is 100% effective in kids 12 to 15. (Justin Tallis-Pool/Getty Ima...
Jen Christensen, CNN

What are the COVID-19 vaccine side effects in young kids? Experts seek to ease parents’ concerns

Experts look at what side effects to expect from the COVID vaccine for children six months and older.
6 days ago
The Nurse Crisis and Patent Risk....
Debbie Worthen

Utah registered nurses are leaving the field, creating the ‘perfect storm’

"Without nurses, we can't have hospitals." Utah nurses are overworked and underpaid. Some say it's put people at risk.
7 days ago
Four-year-old Viola Fairfax-Panza Getting her COVID-19 vaccination, held by her mother Keke Fairfax...
Jed Boal

Salt Lake Co. distributes COVID vaccines for children 6-months and older

Salt Lake County begins COVID-19 vaccinations for children 6 months and older.
7 days ago
U.S. President Joe Biden speaks about Covid-19 vaccines for children, in the Roosevelt Room of the ...
ZEKE MILLER and JOSH BOAK, Associated Press

Biden visits clinic, celebrates COVID shots for kids under 5

President Joe Biden is celebrating that virtually all Americans can now get a COVID-19 shot after the authorization of vaccines for kids under 5 over the weekend.
7 days ago
FILE (Photo by Joe Raedle/Getty Images)...
MIKE STOBBE, ASSOCIATED RPESS

US opens COVID vaccine to little kids; shots begin this week

The U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers. The shots will become available this week, expanding the nation’s vaccination campaign to children as young as 6 months.
9 days ago

Sponsored Articles

hand holding 3d rendering mobile connect with security camera for security solutions...
Les Olson

Wondering what security solutions are right for you? Find out more about how to protect your surroundings

Physical security helps everyone. Keep your employees, clients, and customers safe with security solutions that protect your workplace.
Many rattan pendant lights, hay hang from the ceiling.Traditional and simple lighting....
Lighting Design

The Best Ways to Style Rattan Pendant Lighting in Your Home

Rattan pendant lights create a rustic and breezy feel, and are an easy way to incorporate this hot trend into your home decor.
Earth day 2022...
1-800-GOT-JUNK?

How Are You Celebrating Earth Day 2022? | 4 Simple Ways to Celebrate Earth Day and Protect the Environment

Earth Day is a great time to reflect on how we can be more environmentally conscious. Here are some tips for celebrating Earth Day.
Get Money Online...

More Ways to Get Money Online Right Now in Your Spare Time

Here are 4 easy ways that you can get more money online if you have some free time and want to make a little extra on the side.
Lighting trends 2022...

Lighting Trends 2022 | 5 Beautiful Home Lighting Trends You Can Expect to See this Year and Beyond

This is where you can see the latest lighting trends for 2022 straight from the Lightovation Show at the Dallas World Trade Center.
What Can't You Throw Away in the Trash...

What Can’t You Throw Away in the Trash? | 5 Things You Shouldn’t Throw in to Your Trash Can

What can't you throw away in the trash? Believe it or not, there are actually many items that shouldn't be thrown straight into the trash.
Pfizer asks US officials to OK promising COVID-19 pill